Instrument Inactif

Communiqués ObsEva SA Swiss Exchange

Actions

OBSN

CH1260041939

Recherche biotechnologique et médicale

Communiqués

20/04/23	ObsEva Announces Change of Central Securities Depositary	GL
20/04/23	ObsEva Announces Change of Central Securities Depositary	GL
31/03/23	ObsEva Files Year End 2022 Financial Statements	GL
22/03/23	OBSEVA SA : Other Events (form 8-K)	AQ
15/03/23	ObsEva : Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange - Form 8-K	PU
15/03/23	OBSEVA SA : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
15/03/23	ObsEva Announces Progress Towards its Plans to Consolidate Operations in Switzerland: Delisting of OBSV from The Nasdaq Stock Market effective March 23, 2023	GL
15/03/23	ObsEva Announces Progress Towards its Plans to Consolidate Operations in Switzerland: Delisting of OBSV from The Nasdaq Stock Market effective March 23, 2023	GL
15/03/23	ObsEva Announces Progress Towards its Plans to Consolidate Operations in Switzerland: Delisting of OBSV from The Nasdaq Stock Market effective March 23, 2023	GL
13/03/23	OBSEVA SA : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
13/03/23	ObsEva Announces Update Towards its Strategic Reorganization to Consolidate Operations in Switzerland	GL
13/03/23	ObsEva Announces Update Towards its Strategic Reorganization to Consolidate Operations in Switzerland	GL
01/03/23	OBSEVA SA : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities (form 8-K)	AQ
27/02/23	ObsEva Announces Strategic Reorganization to Consolidate Operations in Switzerland	AQ
24/02/23	OBSEVA SA : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Costs Associated with Exit or Disposal Activities, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
24/02/23	ObsEva Announces Strategic Reorganization to Consolidate Operations in Switzerland	GL
24/02/23	ObsEva Announces Strategic Reorganization to Consolidate Operations in Switzerland	GL
24/02/23	ObsEva Announces Strategic Reorganization to Consolidate Operations in Switzerland	GL
03/01/23	ObsEva : Regulation FD Disclosure - Form 8-K	PU
03/01/23	OBSEVA SA : Regulation FD Disclosure (form 8-K)	AQ
19/12/22	ObsEva Announces Dismissal of Moratorium Proceedings	GL
19/12/22	ObsEva Announces Dismissal of Moratorium Proceedings	GL
19/12/22	ObsEva Announces Dismissal of Moratorium Proceedings	GL
14/12/22	ObsEva Evidences Compliance with Nasdaq’s Stockholder’s Equity Rule and Announces Moratorium Dismissal Request Filing	GL
14/12/22	ObsEva Evidences Compliance with Nasdaq’s Stockholder’s Equity Rule and Announces Moratorium Dismissal Request Filing	AQ